Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study

Table 3 Treatment related adverse events

	No. of patients (n = 42)	%
Hypertension (Grade I)	7	16.7
Proteinuria (Grade II)	2	4.8
Febrile neutropenia (Grade III)	1	2.4
Arterial thrombosis (Grade II)	1	2.4
Venous thrombosis (Grade II)	1	2.4
Toxicity related deaths	1	2.4

ISSN: 1471-2407